Market Currents
More on Baxter (BAX) / Gambro deal: the acquisition, Baxter's largest ever, combines the second...
-
Tuesday, December 4, 2012, 9:07 AM ETMore on Baxter (BAX) / Gambro deal: the acquisition, Baxter's largest ever, combines the second and third largest manufacturers of dialysis equipment, so it could arouse antitrust concerns. Baxter expects synergies of $300M a year by 2017, but says the deal will cut adjusted EPS by $0.10-$0.15 next year and be neutral or add to earnings in 2014, and then add to profit after that. (Webcast) (PR)
Other date
Latest Articles
